ISU Abxis Co., Ltd. (KOSDAQ:086890)
South Korea · Delayed Price · Currency is KRW 5,010.00
-10.00 (-0.20%)
At close: Mar 12, 2026
ISU Abxis Market Cap
ISU Abxis has a market cap or net worth of 204.01 billion as of March 13, 2026. Its market cap has increased by 10.33% in one year.
Market Cap
204.01B
Enterprise Value
201.54B
Revenue
66.39B
Ranking
n/a
PE Ratio
7.87
Stock Price
5,010.00
Market Cap Chart
Since February 3, 2009, ISU Abxis's market cap has increased from 55.97B to 204.01B, an increase of 264.52%. That is a compound annual growth rate of 7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 204.01B | -0.84% |
| Dec 30, 2025 | 205.73B | 28.77% |
| Dec 30, 2024 | 159.77B | -23.70% |
| Dec 28, 2023 | 209.40B | 9.75% |
| Dec 29, 2022 | 190.80B | -34.58% |
| Dec 30, 2021 | 291.68B | 43.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 339.27B |
| Genome & Company | 289.96B |
| Bio Solution | 272.67B |
| ABION | 257.69B |
| Kangstem Biotech | 248.77B |
| TiumBio | 207.91B |
| Ensol Biosciences | 197.77B |
| Prestige Biologics | 196.33B |